GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Kinarus Therapeutics Holding AG (XSWX:KNRS) » Definitions » EPS (Basic)

Kinarus Therapeutics Holding AG (XSWX:KNRS) EPS (Basic) : CHF-0.00 (TTM As of Dec. 2021)


View and export this data going back to 1999. Start your Free Trial

What is Kinarus Therapeutics Holding AG EPS (Basic)?

Kinarus Therapeutics Holding AG's basic earnings per share (Basic EPS) for the six months ended in Dec. 2021 was CHF-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2021 was CHF-0.00.

Kinarus Therapeutics Holding AG's EPS (Diluted) for the six months ended in Dec. 2021 was CHF-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 was CHF-0.00.

Kinarus Therapeutics Holding AG's EPS without NRI for the six months ended in Dec. 2021 was CHF-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2021 was -0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Kinarus Therapeutics Holding AG EPS (Basic) Historical Data

The historical data trend for Kinarus Therapeutics Holding AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kinarus Therapeutics Holding AG EPS (Basic) Chart

Kinarus Therapeutics Holding AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.01 - -

Kinarus Therapeutics Holding AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kinarus Therapeutics Holding AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Kinarus Therapeutics Holding AG's Basic EPS for the fiscal year that ended in Dec. 2021 is calculated as

Basic EPS (A: Dec. 2021 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.143-0)/163.768
=-0.00

Kinarus Therapeutics Holding AG's Basic EPS for the quarter that ended in Dec. 2021 is calculated as

Basic EPS (Q: Dec. 2021 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.176-0)/163.768
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kinarus Therapeutics Holding AG  (XSWX:KNRS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Kinarus Therapeutics Holding AG EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Kinarus Therapeutics Holding AG's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Kinarus Therapeutics Holding AG (XSWX:KNRS) Business Description

Traded in Other Exchanges
N/A
Address
3, Avenue de Florimont, Lausanne, CHE, CH-1006
Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The company operates in one business segment which includes Charters. The products provided by the company include Aircraft sales, Charter sales, and Aircraft consultancy.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Headlines

No Headlines